特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
935351

リポソームドラッグデリバリーの世界市場:2027年までの予測、新型コロナウイルス感染症(COVID-19)の影響と世界市場の分析

Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Technology; Application

出版日: | 発行: The Insight Partners | ページ情報: 英文 177 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
リポソームドラッグデリバリーの世界市場:2027年までの予測、新型コロナウイルス感染症(COVID-19)の影響と世界市場の分析
出版日: 2020年04月30日
発行: The Insight Partners
ページ情報: 英文 177 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のリポソームドラッグデリバリー市場は、2019年の35億9,441万米ドルから2027年には69億9,295万米ドルに拡大すると予想されており、2020年から2027年までのCAGRは8.8%になる見通しです。

当レポートは、世界のリポソームドラッグデリバリー市場を調査したもので、市場の概況や力学、製品別、技術別、用途別、地域別の分析、COVID-19パンデミックの影響、業界の状況、企業プロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 調査レポートのガイダンス
  • 市場セグメンテーション

第2章 主な調査結果

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 市場の状況

  • 概要
  • PEST分析
  • 専門家の意見

第5章 市場の力学

  • 成長促進要因
  • 成長阻害要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場の分析

  • 世界市場の収益予測と分析
  • 地域別の収益予測と分析
  • 主要企業の立ち位置

第7章 市場分析:製品別

  • 概要
  • 収益ベース市場シェア:製品別
  • ドキソルビシンリポソーム
  • パクリタキセルリポソーム
  • アムホテリシンB リポソーム
  • その他

第8章 市場分析:技術別

  • 概要
  • 市場分析:技術別
  • ステルスリポソーム技術
  • 非PEG化リポソーム技術
  • DepoFoamリポソーム技術
  • Lysolipid Thermally Sensitive Liposome (LTSL)技術

第9章 市場分析:用途別

  • 概要
  • 市場分析:用途別
  • 真菌性疾患
  • がん治療
  • 疼痛管理
  • ウイルスワクチン
  • 光線力学療法

第10章 各地域市場の分析

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第11章 COVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他

第12章 業界の情勢

  • 概要
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Luye Pharma Group
  • Johnson & Johnson Services, Inc.
  • Ipsen Pharma
  • Gilead Sciences, Inc.
  • Celsion, Inc.
  • Astellas Pharma Inc.
  • Acrotech Biopharma LLC
  • Pacira BioSciences、Inc.

第14章 付録

図表

LIST OF TABLES

  • Table 1. R&D Investments by major pharmaceutical companies
  • Table 2. North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 20. United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 21. United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 22. United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 23. France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 25. France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 36. China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 37. China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 41. India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 42. India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 43. India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 45. South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 46. South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East & Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Middle East & Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Middle East & Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Saudi Arabia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Saudi Arabia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Saudi Arabia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 56. UAE Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 57. UAE Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 58. UAE Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Brazil Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Recent Organic Growth Strategies in the Liposome Drug Delivery Market
  • Table 72. Recent Inorganic Growth Strategies In The Liposome Drug Delivery Market
  • Table 73. Glossary of Terms, Liposome Drug Delivery Market

LIST OF FIGURES

  • Figure 1. Liposome Drug Delivery Market Segmentation
  • Figure 2. Liposome Drug Delivery Segmentation, By Region
  • Figure 3. Global Liposome Drug Delivery Market Overview
  • Figure 4. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Liposome Drug Delivery Market, By Geography (US$ Million)
  • Figure 7. Global Liposome Drug Delivery Market, Industry Landscape
  • Figure 8. Global Liposome Drug Delivery Market- Leading Country Markets (US$ Million)
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South and Central America PEST Analysis
  • Figure 14. Global Liposome Drug Delivery Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 15. Global Liposome Drug Delivery Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 16. Market Positioning Of Key Players In Global Liposome Drug Delivery Market
  • Figure 17. Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
  • Figure 18. Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • Figure 23. Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • Figure 28. Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. North America: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 34. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 35. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 36. US: Liposome Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Europe: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 40. Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 42. Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Asia Pacific: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 48. Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 50. China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. Middle East & Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
  • Figure 58. Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 64. Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Impact of COVID-19 Pandemic In North American Country Markets
  • Figure 67. Impact of COVID-19 Pandemic In European Country Markets
  • Figure 68. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 69. Impact Of COVID-19 Pandemic In Rest of the World Market
目次
Product Code: TIPRE00010407

The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.

The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery solutions, increasing R&D expenditures in pharmaceutical companies. However, high cost involved in the development of drug delivery systems is expected to obstruct the growth of the market to a certain extent during the forecast period.

With the improvements in medical science and certain oral drug delivery technologies, the noninvasive mode of drug delivery system is now ready to compete with traditional methods of injectable and painful routes of drug delivery. The non-invasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by noninvasive routes due to decreased pain involved in drug delivery. Therefore, these techniques are considered to be a preferred mode of drug delivery. The traditional drug delivery techniques, such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations owing to negative aspects associated with the traditional drug delivery techniques. The noninvasive method of drug delivery system has simplified dosing schedules and is accustomed to the patients. Moreover, noninvasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing costs are also comparatively less for noninvasive dosage forms than injections. Thus, due to advantages offered by noninvasive drug delivery devices, the liposome drug delivery market is expected to witness growth during the forecast period.

The global liposome drug delivery market is segmented into product, technology, application, and geography. The liposome drug delivery market, by product, is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest share by product owing to the high efficacy of the drug exhibited in the treatment of cancer. Moreover, the liposomal doxorubicin is beneficial over its traditional counterparts in terms of toxicity and targeted drug delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi's sarcoma and multiple myeloma. Based on technology, the liposome drug delivery market is segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. Based on application, the liposome drug delivery market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy.

Some of the crucial secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, National Institute of Cancer Prevention and Research (NICPR), Ministry of Food and Drug Safety (MFDS), International Diabetes Federation (IDF), and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liposome drug delivery market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Liposome Drug Delivery Market - By Product
    • 1.3.2 Global Liposome Drug Delivery Market - By Technology
    • 1.3.3 Global Liposome Drug Delivery Market - By Application
    • 1.3.4 Global Liposome Drug Delivery Market - By Geography

2. Liposome Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Liposome Drug Delivery - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe- PEST Analysis
    • 4.2.2 Asia Pacific- PEST Analysis
    • 4.2.3 Middle East & Africa
    • 4.2.4 South and Central America
  • 4.3 Expert Opinion

5. Global Liposome Drug Delivery Market - Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Involved in Development of Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Liposome Drug Delivery Market - Global Analysis

  • 6.1 Global Liposome Drug Delivery Market Revenue Forecast And Analysis
  • 6.2 Global Liposome Drug Delivery Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Liposome Drug Delivery Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
  • 7.3 Liposomal Doxorubicin
    • 7.3.1 Overview
    • 7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Liposomal Paclitaxel
    • 7.4.1 Overview
    • 7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Liposomal Amphotericin B
    • 7.5.1 Overview
    • 7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Liposome Drug Delivery Market - By Technology

  • 8.1 Overview
  • 8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • 8.3 Stealth Liposome Technology
    • 8.3.1 Overview
    • 8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Non-PEGylated Liposome Technology
    • 8.4.1 Overview
    • 8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DepoFoam Liposome Technology
    • 8.5.1 Overview
    • 8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
    • 8.6.1 Overview
    • 8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Liposome Drug Delivery Market - By Application

  • 9.1 Overview
  • 9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • 9.3 Fungal Diseases
    • 9.3.1 Overview
    • 9.3.2 Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Cancer Therapy
    • 9.4.1 Overview
    • 9.4.2 Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Pain Management
    • 9.5.1 Overview
    • 9.5.2 Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Viral Vaccine
    • 9.6.1 Overview
    • 9.6.2 Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Photodynamic Therapy
    • 9.7.1 Overview
    • 9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Liposome Drug Delivery Market - Geographic Analysis

  • 10.1 North America: Liposome Drug Delivery Market
    • 10.1.1 Overview
    • 10.1.2 North America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Liposome Drug Delivery Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Liposome Drug Delivery Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.4 South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.4 Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Liposome Drug Delivery Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
    • 10.4.7 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Saudi Arabia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 UAE Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 South Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Liposome Drug Delivery Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic On Global Liposome Drug Delivery Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Liposome Drug Delivery Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview

13. Liposome Drug Delivery Market -Company Profiles

  • 13.1 Takeda Pharmaceutical Company Limited
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Novartis AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Luye Pharma Group
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson & Johnson Services, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Ipsen Pharma
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Gilead Sciences, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Celsion, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Astellas Pharma Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Acrotech Biopharma LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Pacira BioSciences, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.